Late-Breaking Scientific Abstracts

The Canadian Stroke Congress welcomes the submission of late-breaking scientific abstracts or on-going clinical trials starting June 10, 2015 through to July 15, 2015. Late-breaking scientific abstracts and ongoing clinical trials may be submitted using the on-line abstract submission site.  Please follow the “Abstract Submission Guidelines” below.

Who May Submit?

Late-Breaking Scientific Abstracts
Late-breaking scientific abstracts should feature recent high-impact scientific discoveries. The Canadian Stroke Congress will not accept late-breaking scientific abstracts that have been accepted for an international meeting, and that will be published (print or online) and/or presented prior to October 1, 2015.

Late-breaking scientific abstracts will be peer reviewed but will not be published.  Highly ranked late-breaking abstracts may be featured either as oral or traditional paper display posters.

Abstract Submission Guidelines

  • Abstracts are welcome from national and international applicants from all disciplines. Authors may submit multiple abstracts.
  • Abstracts may be submitted in English or French and presentations at the Congress may be given in either language.
  • Presenters must register for the Congress and will be required to pay the appropriate registration fee.
  • Applicants should categorize their abstract based on one of the six subject area categories provided in the abstract submission system.
  • Applicants should indicate the format they would prefer to present their abstracts:
    1. Oral: A 10-minute oral presentation in a plenary or breakout session.  Spaces are limited.  Those who are not successful in securing an oral presentation slot will be offered to present their abstract via a mini-platform or display poster format.
    2. Display Poster: A traditional paper (non-digital) poster.  Presenters will be asked to be available to answer questions during set times during the Congress.  Display posters will be available for viewing to all Congress delegates throughout the Congress.
  • All abstracts will be peer-reviewed.
  • Each abstract should be a maximum of 300 words (excluding title and authors) and should consist of four separate paragraphs:
    1. Background: briefly describing the problem or issue being addressed
    2. Methods: describing how the study was performed
    3. Results: describing the salient results or findings
    4. Conclusions: describing what the authors conclude from these results.
  • Research presented in abstracts must conform to CIHR guidelines for experimental procedures. All investigations involving humans and animals must have been conducted in conformity with these principles.
  • Authors must declare any financial interest in a company (or its competitors) that makes a product discussed in the abstract.

Click here to visit the abstract submission website.